Initial Experience With Hyperthermic Intraperitoneal Chemotherapy | Zendy

Olivıer Turrini | Zendy; Éric Lambaudie | Zendy; Marion Faucher | Zendy; F. Viret | Zendy; Jean Louis Blache | Zendy; Gilles Houvenaeghel | Zendy; JeanRobert Delpéro | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Initial Experience With Hyperthermic Intraperitoneal Chemotherapy

Author(s) -

Olivıer Turrini,

Éric Lambaudie,

Marion Faucher,

F. Viret,

Jean Louis Blache,

Gilles Houvenaeghel,

JeanRobert Delpéro

Publication year - 2012

Publication title -

archives of surgery

Language(s) - English

Resource type - Journals

eISSN - 1538-3644

pISSN - 0004-0010

DOI - 10.1001/archsurg.2012.988

Subject(s) - medicine , hyperthermic intraperitoneal chemotherapy , perioperative , surgery , cytoreductive surgery , peritoneal carcinomatosis , oxaliplatin , blood transfusion , blood loss , chemotherapy , colorectal cancer , cancer , ovarian cancer

Until 2004, we treated peritoneal carcinomatosis with cytoreductive surgery accompanied by perioperative systemic chemotherapy. From October 2004, we decided to initiate a hyperthermic intraperitoneal chemotherapy (HIPEC) program for this condition.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research